Screening for Obstructive Sleep Apnea Among Members of an Internet Weight Loss Community

Effect of a Web-Based Presentation on Communication With Healthcare Providers

The current study was a pilot, double blind, randomized controlled trial to (1) evaluate the feasibility of an online obstructive sleep apnea (OSA) screening intervention, (2) estimate effect size for planning of future studies, and (3) test the hypothesis that the intervention, compared to a control condition, would lead more individuals to discuss OSA with their healthcare provider.

Study Overview

Study Type

Interventional

Enrollment (Actual)

168

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Houston, Texas, United States, 77030
        • University of Texas Medical School, Houston

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Member of SparkPeople.com community and logged on within previous month
  • Live in the US

Exclusion Criteria:

  • Prior diagnosis of OSA
  • Prior discussions with healthcare provider about OSA

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
Brief, theory-based, online assessment of OSA risk followed by risk-tailed OSA presentation.
Brief, theory-based, online assessment of OSA risk followed by risk-tailed OSA presentation.
No Intervention: Control
No risk assessment or presentation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Online questionnaire asking whether subject has discussed OSA with healthcare provider since enrolling in study
Time Frame: 12 weeks
12 weeks

Secondary Outcome Measures

Outcome Measure
Time Frame
Online questionnaire asking whether subject has plans to discuss OSA with healthcare provider, if not done already
Time Frame: 12 weeks
12 weeks
Online questionnaire asking whether subject has undergone testing and treatment for OSA since enrolling in study
Time Frame: 12 weeks
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Kevin O Hwang, MD, MPH, University of Texas Medical School, Houston

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2008

Primary Completion (Actual)

October 1, 2008

Study Completion (Actual)

October 1, 2008

Study Registration Dates

First Submitted

December 12, 2008

First Submitted That Met QC Criteria

December 12, 2008

First Posted (Estimate)

December 16, 2008

Study Record Updates

Last Update Posted (Estimate)

December 16, 2008

Last Update Submitted That Met QC Criteria

December 12, 2008

Last Verified

December 1, 2008

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Obstructive Sleep Apnea

Clinical Trials on Obstructive sleep apnea screening intervention

3
Subscribe